# Vertex Pharmaceuticals Inc. (VRTX) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $12.00B |
| 2024 | $11.02B |
| 2023 | $9.87B |
| 2022 | $8.93B |
| 2021 | $7.57B |
| 2020 | $6.21B |
| 2019 | $4.16B |
| 2018 | $3.05B |
| 2017 | $2.49B |
| 2016 | $1.70B |
| 2015 | $1.03B |
| 2014 | $580M |
| 2013 | $1.21B |
| 2012 | $1.53B |
| 2011 | $1.41B |
| 2010 | $143M |
| 2009 | $102M |
| 2008 | $176M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $2.99B |
| 2025-09-30 | $3.08B |
| 2025-06-30 | $2.96B |
| 2025-03-31 | $2.77B |
| 2024-09-30 | $2.77B |
| 2024-06-30 | $2.65B |
| 2024-03-31 | $2.69B |
| 2023-09-30 | $2.48B |
| 2023-06-30 | $2.49B |
| 2023-03-31 | $2.37B |
| 2022-09-30 | $2.33B |
| 2022-06-30 | $2.20B |
| 2022-03-31 | $2.10B |
| 2021-09-30 | $1.98B |
| 2021-06-30 | $1.79B |
| 2021-03-31 | $1.72B |
| 2020-09-30 | $1.54B |
| 2020-06-30 | $1.52B |
| 2020-03-31 | $1.52B |
| 2019-09-30 | $950M |
| 2019-06-30 | $941M |
| 2019-03-31 | $858M |
| 2018-09-30 | $785M |
| 2018-06-30 | $752M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/VRTX/revenue)